HHL:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 8.72

Change

-0.04 (-0.46)%

Market Cap

N/A

Volume

0.08M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.70 (-1.74%)

CAD 2.88B
ZWU:CA BMO Covered Call Utilities ETF

+0.02 (+0.18%)

CAD 1.94B
XHC:CA iShares Global Healthcare (CAD..

-0.17 (-0.23%)

CAD 0.65B
XIT:CA iShares S&P/TSX Capped Informa..

-0.93 (-1.60%)

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

-0.42 (-1.94%)

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

-0.31 (-1.66%)

CAD 0.63B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.07 (+0.31%)

CAD 0.45B
CWW:CA iShares Global Water Common Cl..

-0.20 (-0.33%)

CAD 0.34B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.01 (+0.03%)

CAD 0.32B
COW:CA iShares Global Agriculture Com..

+0.15 (+0.24%)

CAD 0.28B

ETFs Containing HHL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.59% 37% F 42% F
Dividend Return 6.60% 100% F 96% N/A
Total Return 15.19% 71% C- 58% F
Trailing 12 Months  
Capital Gain 14.29% 31% F 40% F
Dividend Return 9.24% 93% A 97% N/A
Total Return 23.52% 46% F 54% F
Trailing 5 Years  
Capital Gain 20.44% 29% F 50% F
Dividend Return 36.31% 100% F 96% N/A
Total Return 56.75% 49% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 2.14% N/A N/A 46% F
Dividend Return 8.83% N/A N/A 62% D
Total Return 6.69% N/A N/A 98% N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.86% N/A N/A 55% F
Risk Adjusted Return 99.63% N/A N/A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike